Acetyl hexapeptide-3 or acetyl hexapeptide-8 (sources differ) is a synthetic anti-wrinkle cosmetics ingredient. It is a peptide which is a fragment of SNAP-25, a substrate of botulinum toxin (Botox).

Market Analysis and Insights: Global and United States Acetyl Hexapeptide-8 Market
This report focuses on global and United States Acetyl Hexapeptide-8 market.
In 2020, the global Acetyl Hexapeptide-8 market size was US$ XX million and it is expected to reach US$ XX million by the end of 2027, with a CAGR of XX% during 2021-2027. In United States the Acetyl Hexapeptide-8 market size is expected to grow from US$ XX million in 2020 to US$ XX million by 2027, at a CAGR of XX% during the forecast period.

Global Acetyl Hexapeptide-8 Scope and Market Size
Acetyl Hexapeptide-8 market is segmented by region (country), players, by Type, and by Application. Players, stakeholders, and other participants in the global Acetyl Hexapeptide-8 market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by region (country), by Type and by Application in terms of revenue and forecast for the period 2016-2027.
For United States market, this report focuses on the Acetyl Hexapeptide-8 market size by players, by Type, and by Application, for the period 2016-2027. The key players include the global and local players which play important roles in United States.

Segment by Type
Purity: 98%
Purity: 99%
Other

Segment by Application
Cosmetics and Skin Care
Pharmaceuticals
Others

By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE

By Company
Lipotec S.A.U
LipoTrue SL
Shanghai Soho-Yiming Pharmaceuticals
Active Peptide Company
Puyer Group
Hangzhou Go Top Peptide Biotech
CosBioTech
Spec-Chem Industry Inc.